Market Overview

UPDATE: Stifel Nicolaus Raises PT to $30 on Team Health Holdings on Outlook

Related TMH
10 Notable Stocks Trading Ex-Dividend Thursday, November 3
Benzinga's Top Downgrades

Stifel Nicolaus reiterated its Buy rating on Team Health Holdings (NYSE: TMH) and raised its price target from $29 to $30.

Stifel Nicolaus commented, "Team stands to benefit from healthcare reform in two ways. Raising Medicaid payments to physicians for primary care services to the level of Medicare in 2013-14 will boost revenues for Team's emergency department services, and expansion of insurance coverage to the uninsured scheduled to begin in 2014 will reduce the number of low- or no-pay uninsured patients treated in Team's emergency departments. We believe that Team's continued strong fundamental performance illustrates that health reform is a not a prerequisite for share price appreciation. Our earnings model, target price, and Buy rating all assume no health reform benefit."

Team Health Holdings closed at $26.61 on Wednesday.

Latest Ratings for TMH

Dec 2016JefferiesDowngradesBuyHold
Nov 2016Wells FargoDowngradesOutperformMarket Perform
Oct 2016Leerink SwannDowngradesOutperformMarket Perform

View More Analyst Ratings for TMH
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Price Target Intraday Update Analyst Ratings


Related Articles (TMH)

View Comments and Join the Discussion!